Try

TG Therapeutics Inc. Common Stock

TGTXUnited States

68 filed reports · 600 financial concepts · 0 earnings calls · 2 media appearances

Filed reports

68 reports · Jun 2011 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 2 guidance figures, 140 commentary passages.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR505,349Mar 2012 to Jun 2026
Annual · 10-KSEC EDGAR154,482Dec 2013 to Dec 2025
Annual · 10-K/ASEC EDGAR11Dec 2023
Current · 8-KSEC EDGAR12Jun 2026
Quarterly · 10-Q/ASEC EDGAR1246Jun 2011

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 5, 20261Open
FY2026 Q210-QJun 30, 2026Aug 5, 2026336Open
FY2026 Q28-KJun 30, 2026Aug 3, 20262Open
FY2026 Q110-QMar 31, 2026May 6, 20261Open
FY2026 Q110-QMar 31, 2026May 6, 2026208Open
FY202510-KDec 31, 2025Feb 27, 20261Open
FY202510-KDec 31, 2025Feb 27, 2026716Open
FY2025 Q310-QSep 30, 2025Nov 5, 20251Open
FY2025 Q310-QSep 30, 2025Nov 5, 2025221Open
FY2025 Q210-QJun 30, 2025Aug 8, 2025121Open
FY2025 Q210-QJun 30, 2025Aug 8, 20251Open
FY2025 Q110-QMar 31, 2025May 9, 2025134Open

Financial data

600 concepts · 10,080 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial598 concepts · 9,945 facts · Dec 2001 to Aug 2026

  • Cash and cash equivalents at carrying value79 · Dec 2009 to Jun 2026
  • Operating income loss73 · Jun 2010 to Jun 2026
  • Research and development expense73 · Jun 2010 to Jun 2026
  • Common stock shares issued72 · Dec 2010 to Jun 2026
  • Assets71 · Dec 2010 to Jun 2026
  • Assets current71 · Dec 2010 to Jun 2026
  • Change in fair value of notes payable71 · Jun 2012 to Jun 2026
  • Common stock par or stated value per share71 · Dec 2010 to Jun 2026
  • Common stock shares authorized71 · Dec 2010 to Jun 2026
  • Common stock shares outstanding71 · Dec 2010 to Jun 2026
  • Common stock value71 · Dec 2010 to Jun 2026
  • Liabilities71 · Dec 2010 to Jun 2026
  • Liabilities and stockholders equity71 · Dec 2010 to Jun 2026
  • Liabilities current71 · Dec 2010 to Jun 2026
  • Noncash compensation71 · Jun 2012 to Jun 2026
  • Nonoperating income expense71 · Jun 2012 to Jun 2026
  • Other assets current71 · Dec 2010 to Jun 2026
  • Increase decrease in deferred revenue70 · Sep 2012 to Jun 2026
  • Increase decrease in other current assets70 · Sep 2012 to Jun 2026
  • Preferred stock par or stated value per share70 · Dec 2010 to Jun 2026
  • Preferred stock shares authorized70 · Dec 2010 to Jun 2026
  • Share based compensation70 · Sep 2012 to Jun 2026
  • Additional paid in capital68 · Dec 2012 to Jun 2026
  • Deferred compensation liability current68 · Dec 2012 to Jun 2026

Product1 concepts · 133 facts · Dec 2019 to Jun 2026

  • Revenue133 · Dec 2019 to Jun 2026

Guidance1 concepts · 2 facts · Aug 2026

  • Revenue Guidance2 · Aug 2026

Segments

133 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service6 members · 133 facts

  • Product43 · Dec 2020 to Jun 2026
  • License33 · Dec 2019 to Jun 2026
  • License Revenue17 · Dec 2021 to Jun 2026
  • Other Revenue14 · Dec 2021 to Dec 2025
  • Milestone13 · Dec 2022 to Dec 2025
  • Royalty13 · Dec 2022 to Dec 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary87 claims from 8 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary140 claims from 8 reports · Sep 2024 to Jun 2026
  • Risk-factor changes20 claims from 1 reports · Dec 2025
  • Risk factors150 risks from 2 annual reports · 2024 to 2025

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

2 appearances

Podcasts, interviews and conference appearances by the company's executives, with their claims.

  • TV interviews2 · Apr 2021 to Aug 2021

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

TG Therapeutics Inc. Common Stock (TGTX) data · FactIQ